Arm itched there; Still red; Broke out with this rage rash/not really round but it has fingers/broke out/rash/size of a kiwi; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Arm itched there), RASH ERYTHEMATOUS (Still red) and RASH (Broke out with this rage rash/not really round but it has fingers/broke out/rash/size of a kiwi) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A, 040A21A and 007M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PANTOPRAZOLE [PANTOPRAZOLE SODIUM SESQUIHYDRATE]), VERAPAMIL, ATORVASTATIN CALCIUM (LIPITOR), CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]), CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]), VITAMIN D3 and POLYCARBOPHIL CALCIUM (FIBER) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Broke out with this rage rash/not really round but it has fingers/broke out/rash/size of a kiwi). On an unknown date, the patient experienced RASH PRURITIC (Arm itched there) and RASH ERYTHEMATOUS (Still red). At the time of the report, RASH PRURITIC (Arm itched there), RASH ERYTHEMATOUS (Still red) and RASH (Broke out with this rage rash/not really round but it has fingers/broke out/rash/size of a kiwi) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included lavender lotion. This case concerns a 69 year old female with no reported medical history , who experienced Non-serious , expected events of Rash which occurred 20 days after vaccination with the third dose ( booster dose ) . On an unknown date after vaccination with the 3rd dose  she experienced Non-serious, unexpected events   of Rash pruritic , rash erythematous  after vaccination with the 3rd  dose. The re-challenge for this case is not applicable since the events occurred after the 3rd dose and no additional doses will be given also the events outcome is unknown. . The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.; Sender's Comments: This case concerns a 69 year old female with no reported medical history , who experienced Non-serious , expected events of Rash which occurred 20 days after vaccination with the third dose ( booster dose ) . On an unknown date after vaccination with the 3rd dose  she experienced Non-serious, unexpected events   of Rash pruritic , rash erythematous  after vaccination with the 3rd  dose. The re-challenge for this case is not applicable since the events occurred after the 3rd dose and no additional doses will be given also the events outcome is unknown. . The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report.